Ugwu Ejiofor T, Orjioke Casmir J G, Young Ekenechukwu E
Department of Internal Medicine, Enugu State University of Science and Technology, Enugu, Nigeria.
Department of Internal Medicine, University of Nigeria Nsukka, Nsukka, Nigeria.
Curr Diabetes Rev. 2018;14(2):175-181. doi: 10.2174/1573399812666161014111618.
Self Monitoring of Blood Glucose (SMBG) is a useful adjunct to lifestyle modification and medications for optimal management of type 2 Diabetes Mellitus (DM). This study was aimed at evaluating the practice, cost and associations of SMBG in subjects with type 2 DM in Enugu, Nigeria.
In a cross-sectional survey conducted at the diabetes clinic in three hospitals, 366 type 2 diabetic subjects aged 18-65 years were consecutively interviewed. Socio-demographic and clinical information were documented and glycated hemoglobin was performed for all the participants.
A total of 318 subjects with mean age of 49.0 ± 9.4 years completed the study. 304 subjects (95.6%) reported that they were aware of SMBG and 60.7% practiced SMBG at frequencies ranging from ≥ 1/day (7.9%), ≥ 1/week (26.1%) or < 1/week (26.7%). 39.3% of the respondents did not perform any SMBG. Lack of finance was the predominant reason for not performing any SMBG. The median monthly cost of performing SMBG excluding the cost of meters was N2,000 (USD 6.7) per patient, amounting to annual societal cost of N37.8 billion (USD 126 million). Significant associates of performing any SMBG were longer DM duration, previous participation in diabetes education, insulin treatment and infrequent hospitalization.
Despite high awareness, SMBG practice is grossly inadequate and is associated with a huge economic burden that may be unsustainable in a resource-poor country like Nigeria. Measures aimed at reducing the cost of glucometers and strips, and improving diabetes education are recommended.
自我血糖监测(SMBG)是2型糖尿病(DM)优化管理中生活方式改变和药物治疗的有用辅助手段。本研究旨在评估尼日利亚埃努古2型糖尿病患者自我血糖监测的实践情况、成本及相关因素。
在三家医院的糖尿病诊所进行的一项横断面调查中,连续访谈了366名年龄在18 - 65岁的2型糖尿病患者。记录了社会人口统计学和临床信息,并对所有参与者进行了糖化血红蛋白检测。
共有318名平均年龄为49.0±9.4岁的受试者完成了研究。304名受试者(95.6%)报告称他们知晓自我血糖监测,60.7%的人进行自我血糖监测,频率范围为≥1/天(7.9%)、≥1/周(26.1%)或<1/周(26.7%)。39.3%的受访者未进行任何自我血糖监测。资金短缺是未进行自我血糖监测的主要原因。每位患者每月进行自我血糖监测的中位数成本(不包括血糖仪成本)为2000奈拉(6.7美元),这意味着每年社会成本为378亿奈拉(1.26亿美元)。进行任何自我血糖监测的显著相关因素包括糖尿病病程较长、以前参加过糖尿病教育、接受胰岛素治疗以及住院频率较低。
尽管知晓率较高,但自我血糖监测的实践严重不足,且与巨大的经济负担相关,在像尼日利亚这样资源匮乏的国家,这可能是不可持续的。建议采取措施降低血糖仪和试纸的成本,并改善糖尿病教育。